Current trials with intravesical treatment in high-risk BCG-naïve NMIBC
Intravesical therapy with chemotherapy or BCG is the recommended adjuvant treatment after TURBT to minimise the risk of recurrence. BCG shortages continue and BCG is not suitable for… read more.

